Compare CVAC & WDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CVAC | WDI |
|---|---|---|
| Founded | 2000 | 2021 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 732.4M |
| IPO Year | 2020 | N/A |
| Metric | CVAC | WDI |
|---|---|---|
| Price | $4.34 | $13.89 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $6.83 | N/A |
| AVG Volume (30 Days) | ★ 2.0M | 192.6K |
| Earning Date | 11-24-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.80% |
| EPS Growth | ★ 94.02 | N/A |
| EPS | 0.94 | ★ 1.12 |
| Revenue | ★ $83,000,117.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $23.40 | N/A |
| P/E Ratio | ★ $4.40 | $12.82 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.48 | $12.16 |
| 52 Week High | $5.72 | $14.69 |
| Indicator | CVAC | WDI |
|---|---|---|
| Relative Strength Index (RSI) | 31.40 | 37.91 |
| Support Level | $4.00 | $13.61 |
| Resistance Level | $5.20 | $14.00 |
| Average True Range (ATR) | 0.16 | 0.16 |
| MACD | -0.09 | -0.03 |
| Stochastic Oscillator | 23.66 | 34.96 |
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
Western Asset Diversified Income Fund is a newly-organized, diversified, closed-end management investment company. The fund's primary investment objective is to seek high current income.